HOME › DRUGS › AMIVANTAMAB AND HYALURONIDASE-LPUJ
ACTIVE SUBSTANCE / INN

AMIVANTAMAB AND HYALURONIDASE-LPUJ

Brand name(s): RYBREVANT FASPRO
FDA LISTED
PRESCRIPTION
BLA761433
ACTIVE SUBSTANCE
Amivantamab And Hyaluronidase-Lpuj
REGULATORS
FDA
SPONSORS / MAH
JANSSEN BIOTECH
TOTAL APPLICATIONS
1
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
RYBREVANT FASPROBLA761433JANSSEN BIOTECHPrescription

FULL INTELLIGENCE ON AMIVANTAMAB AND HYALURONIDASE-LPUJ

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →